About Polysan
Polysan is a Healthcare company based in Saint Petersburg (Russia) founded in 1992. Polysan is an EU-compliant manufacturer and exporter of original pharmaceutical drugs. It operates on a B2B model. Its website polysan.ru draws about 13 thousand monthly visits. Its focus areas include Pharmaceuticals, Drug Manufacturing and Export Operations. Its legal entity in India is Stpf Polysan Private Limited (U21001KA2024FTC194074). Its competitors include Unither, Akums, Recipharm, Jubilant Life Sciences and CoreRx and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Polysan, established in 1992, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and export operations. Polysan is an EU-compliant manufacturer and exporter of original pharmaceutical drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Saint Petersburg, Russia
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website polysan.ru
- Legal Name Stpf Polysan Private Limited
- Date of Incorporation 18 Oct, 2024
- Jurisdiction Bangalore, Karnataka, India
Associated legal entities of Polysan
Polysan operates through Stpf Polysan Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stpf Polysan Private Limited CIN U21001KA2024FTC194074 | Active | 18 Oct 2024 | Bangalore, Karnataka | – | – | 3 | View details |
Board of directors of Stpf Polysan Private Limited (Polysan)
Stpf Polysan Private Limited is the primary company behind Polysan. The board of Stpf Polysan Private Limited currently have 3 directors; the longest-serving is Praveena Kumar Edurkala Sundara, appointed in 2024.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Praveena Kumar Edurkala Sundara DIN 10812504 | Director | 18 Oct 2024 | 2 yrs | Stpf Polysan Private Limited |
| Dulentsov Aleksandr Aleksandrovich DIN 10812502 | Director | 18 Oct 2024 | 2 yrs | Stpf Polysan Private Limited |
| Aruldas Carlson DIN 10812503 | Director | 18 Oct 2024 | 2 yrs | Stpf Polysan Private Limited |
Competitors of Polysan
Polysan has 8 listed competitors in our database, 5 of them funded. They include Unither, Akums, Recipharm, Jubilant Life Sciences and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| kezzler.com | 2001 | Oslo, Norway | $6.73M | – | Mass serialization solutions for a wide range of industries |
Detailed competitors of Polysan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Polysan
The website of Polysan (polysan.ru) receives about 12.6K visits a month and ranks #2,472,818 among all websites worldwide, #3,396 in Biotechnology and Pharmaceuticals.
- Monthly visits12.6K
▲ 28% vs previous month
- Unique visitors4.3K
per month
- Global rank#2,472,818
among all websites
- Category rank#3,396
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit1.4
- Average visit12 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Polysan. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biosintez.com | 88% | 6.3K | #3,090,383 | View details | |
| petrovax.ru | 88% | 11.3K | #2,070,514 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Polysan (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Polysan
Complete news archive for Polysan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polysan
Polysan was founded in 1992.
Polysan is headquartered in Saint Petersburg, Russia.
Polysan, established in 1992, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and export operations. Polysan is an EU-compliant manufacturer and exporter of original pharmaceutical drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Polysan's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Polysan operates through Stpf Polysan Private Limited.
The legal entities of Polysan currently have 3 directors, including Praveena Kumar Edurkala Sundara, Dulentsov Aleksandr Aleksandrovich, Aruldas Carlson.